Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 80

Similar articles for PubMed (Select 22341195)

1.

Clinical guidance on the use of live attenuated influenza vaccine after inadvertent freezing and warming.

Toback SL, Susla GM, Darling AJ, Ambrose CS.

J Pediatr Nurs. 2012 Apr;27(2):163-7. doi: 10.1016/j.pedn.2010.11.003. Epub 2011 Jan 31.

PMID:
22341195
2.
3.

Safety, vaccine virus shedding and immunogenicity of trivalent, cold-adapted, live attenuated influenza vaccine administered to human immunodeficiency virus-infected and noninfected children.

King JC Jr, Fast PE, Zangwill KM, Weinberg GA, Wolff M, Yan L, Newman F, Belshe RB, Kovacs A, Deville JG, Jelonek M; HIV Influenza Study Group.

Pediatr Infect Dis J. 2001 Dec;20(12):1124-31.

PMID:
11740317
4.

Development of a freeze-stable formulation for vaccines containing aluminum salt adjuvants.

Braun LJ, Tyagi A, Perkins S, Carpenter J, Sylvester D, Guy M, Kristensen D, Chen D.

Vaccine. 2009 Jan 1;27(1):72-9. doi: 10.1016/j.vaccine.2008.10.027. Epub 2008 Oct 28.

PMID:
18973782
5.

Risk factors for improper vaccine storage and handling in private provider offices.

Bell KN, Hogue CJ, Manning C, Kendal AP.

Pediatrics. 2001 Jun;107(6):E100.

PMID:
11389298
6.

Live attenuated influenza vaccine, trivalent, is safe in healthy children 18 months to 4 years, 5 to 9 years, and 10 to 18 years of age in a community-based, nonrandomized, open-label trial.

Piedra PA, Gaglani MJ, Riggs M, Herschler G, Fewlass C, Watts M, Kozinetz C, Hessel C, Glezen WP.

Pediatrics. 2005 Sep;116(3):e397-407.

7.

Live attenuated influenza virus vaccines: new options for the prevention of influenza.

Nichol KL.

Vaccine. 2001 Aug 14;19(31):4373-7. Review.

PMID:
11483261
8.

Efficacy of a single dose of live attenuated influenza vaccine in previously unvaccinated children: a post hoc analysis of three studies of children aged 2 to 6 years.

Block SL, Toback SL, Yi T, Ambrose CS.

Clin Ther. 2009 Oct;31(10):2140-7. doi: 10.1016/j.clinthera.2009.09.014.

PMID:
19922885
9.

Hepatitis B vaccine freezing in the Indonesian cold chain: evidence and solutions.

Nelson CM, Wibisono H, Purwanto H, Mansyur I, Moniaga V, Widjaya A.

Bull World Health Organ. 2004 Feb;82(2):99-105. Epub 2004 Mar 16.

10.

Stabilizing cold-adapted influenza virus vaccine under various storage conditions.

Yannarell DA, Goldberg KM, Hjorth RN.

J Virol Methods. 2002 Apr;102(1-2):15-25.

PMID:
11879689
11.

Stability of live, freeze-dried virus vaccines.

Peetermans J, Colinet G, Bouillet A, D'Hondt E, Stephenne J.

Dev Biol Stand. 1976 Oct;36:291-6.

PMID:
1030427
12.

In vitro stability of lyophilized and reconstituted recombinant activated factor VII formulated for storage at room temperature.

Nedergaard H, Vestergaard S, Jensen PT, Kristiansen MW, Jensen MB, Ostergaard PB, Norsell T, Bjerre J.

Clin Ther. 2008 Jul;30(7):1309-15.

PMID:
18691990
13.

Characterization of the freeze sensitivity of a hepatitis B vaccine.

Chen D, Tyagi A, Carpenter J, Perkins S, Sylvester D, Guy M, Kristensen DD, Braun LJ.

Hum Vaccin. 2009 Jan-Feb;5(1):26-32. Epub 2009 Jan 24.

14.

Stability of seasonal influenza vaccines investigated by spectroscopy and microscopy methods.

Patois E, Capelle MA, Gurny R, Arvinte T.

Vaccine. 2011 Oct 6;29(43):7404-13. doi: 10.1016/j.vaccine.2011.07.067. Epub 2011 Jul 29.

PMID:
21803109
15.

Effects of processing and storage conditions on amyloid beta (1-42) and tau concentrations in cerebrospinal fluid: implications for use in clinical practice.

Schoonenboom NS, Mulder C, Vanderstichele H, Van Elk EJ, Kok A, Van Kamp GJ, Scheltens P, Blankenstein MA.

Clin Chem. 2005 Jan;51(1):189-95. Epub 2004 Nov 11.

16.

Efficacy and safety of 1 and 2 doses of live attenuated influenza vaccine in vaccine-naive children.

Bracco Neto H, Farhat CK, Tregnaghi MW, Madhi SA, Razmpour A, Palladino G, Small MG, Gruber WC, Forrest BD; D153-P504 LAIV Study Group.

Pediatr Infect Dis J. 2009 May;28(5):365-71. doi: 10.1097/INF.0b013e31819219b8.

PMID:
19395948
17.

Cold chain in a hot climate.

Guthridge SL, Miller NC.

Aust N Z J Public Health. 1996 Dec;20(6):657-60.

PMID:
9117976
18.

Comparison of the safety, vaccine virus shedding, and immunogenicity of influenza virus vaccine, trivalent, types A and B, live cold-adapted, administered to human immunodeficiency virus (HIV)-infected and non-HIV-infected adults.

King JC Jr, Treanor J, Fast PE, Wolff M, Yan L, Iacuzio D, Readmond B, O'Brien D, Mallon K, Highsmith WE, Lambert JS, Belshe RB.

J Infect Dis. 2000 Feb;181(2):725-8.

19.

Seasonal influenza vaccines.

Fiore AE, Bridges CB, Cox NJ.

Curr Top Microbiol Immunol. 2009;333:43-82. doi: 10.1007/978-3-540-92165-3_3. Review.

PMID:
19768400
20.

Protective efficacy of live-attenuated influenza vaccine (multivalent, Ann Arbor strain): a literature review addressing interference.

Bandell A, Woo J, Coelingh K.

Expert Rev Vaccines. 2011 Aug;10(8):1131-41. doi: 10.1586/erv.11.73. Review.

PMID:
21854309
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk